Location · Kissimmee, FL
Clinical trials in Kissimmee, FL
39 recruiting studies have a site in Kissimmee, and 1 of them accept healthy volunteers.
39 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Genentech, Inc.
- Location
- Kissimmee, FL + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of DISC-0974-201 in Participants With IBD and Anemia
Disc Medicine, Inc
- Location
- Kissimmee, FL + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
GlaxoSmithKline
- Location
- Kissimmee, FL + 93 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Kissimmee, FL + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Pulmovant, Inc.
- Location
- Kissimmee, FL + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
AbbVie
- Location
- Kissimmee, FL + 9 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Kissimmee, FL + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
GlaxoSmithKline
- Location
- Kissimmee, FL + 13 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 4
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Aurinia Pharmaceuticals Inc.
- Location
- Kissimmee, FL + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Viatris Innovation GmbH
- Location
- Kissimmee, FL + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Kissimmee, FL + 62 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
Amgen
- Location
- Kissimmee, FL + 3 other US sites
- Eligibility basics
- Ages 18–99
- Recruiting
A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
PGP Health
- Location
- Kissimmee, FL + 2 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Kissimmee, FL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Kissimmee, FL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only